Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Verhoef

Showing results (191-200 of 811) with videos related to

Pageof 82
Sort By:
Social Science & Medicine (1982)|February 21, 2006
The scope of naturopathic medicine in Canada: an emerging professionMarja J Verhoef, Heather S Boon, Donatus R Mutasingwa
Current Oncology (Toronto, Ont.)|September 5, 2008
Talking to cancer patients about complementary therapies: is it the physician's responsibility?M J Verhoef, H S Boon, S A Page
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 26, 2005
Are chiropractors interested in participating in immunization awareness and promotion activities?Margaret L Russell, Marja J Verhoef, H Stephen Injeyan
Archives of Internal Medicine|October 24, 1994
Airborne gram-negative bacteria and endotoxin in sick building syndrome. A study in Dutch governmental office buildingsK B Teeuw, C M Vandenbroucke-Grauls, J Verhoef
Journal of Neurochemistry|April 1, 1982
H-Pro-[3H]Leu-Gly-NH2: plasma profile and brain uptake following subcutaneous injection in the ratJ Verhoef, A Prins, H D Veldhuis, et al.
Agents and Actions|January 1, 1986
Rosmarinic acid inhibits external oxidative effects of human polymorphonuclear granulocytesK P van Kessel, E S Kalter, J Verhoef
Complementary Therapies in Medicine|April 2, 2003
Inflammatory bowel disease patients' decisions to use complementary therapies: links to existing models of careC M Scott, M J Verhoef, R J Hilsden
The Journal of Antimicrobial Chemotherapy|May 27, 2005
Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003A C Fluit, A Florijn, J Verhoef, et al.
International Journal of Antimicrobial Agents|July 27, 1999
Surveillance of resistance against antimicrobial agentsJ Verhoef, J F Acar, R Gupta, et al.
The Journal of Infectious Diseases|August 1, 1988
Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trialT Calandra, M P Glauser, J Schellekens, et al.
Pageof 82

Showing results (191-200 of 811) with videos related to

Sort By:
Pageof 82
Social Science & Medicine (1982)|February 21, 2006
The scope of naturopathic medicine in Canada: an emerging professionMarja J Verhoef, Heather S Boon, Donatus R Mutasingwa
Current Oncology (Toronto, Ont.)|September 5, 2008
Talking to cancer patients about complementary therapies: is it the physician's responsibility?M J Verhoef, H S Boon, S A Page
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|May 26, 2005
Are chiropractors interested in participating in immunization awareness and promotion activities?Margaret L Russell, Marja J Verhoef, H Stephen Injeyan
Archives of Internal Medicine|October 24, 1994
Airborne gram-negative bacteria and endotoxin in sick building syndrome. A study in Dutch governmental office buildingsK B Teeuw, C M Vandenbroucke-Grauls, J Verhoef
Journal of Neurochemistry|April 1, 1982
H-Pro-[3H]Leu-Gly-NH2: plasma profile and brain uptake following subcutaneous injection in the ratJ Verhoef, A Prins, H D Veldhuis, et al.
Agents and Actions|January 1, 1986
Rosmarinic acid inhibits external oxidative effects of human polymorphonuclear granulocytesK P van Kessel, E S Kalter, J Verhoef
Complementary Therapies in Medicine|April 2, 2003
Inflammatory bowel disease patients' decisions to use complementary therapies: links to existing models of careC M Scott, M J Verhoef, R J Hilsden
The Journal of Antimicrobial Chemotherapy|May 27, 2005
Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003A C Fluit, A Florijn, J Verhoef, et al.
International Journal of Antimicrobial Agents|July 27, 1999
Surveillance of resistance against antimicrobial agentsJ Verhoef, J F Acar, R Gupta, et al.
The Journal of Infectious Diseases|August 1, 1988
Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trialT Calandra, M P Glauser, J Schellekens, et al.
Pageof 82